The ESMO Deep Dive - Upper Digestive Cancers Webinar Series recordings and slides are available to all ESMO Members.
ESMO Deep Dive: Upper Digestive Cancers – Local Treatment Beyond Surgery of Non-Colorectal Cancers
It is with great pleasure that we invite you to participate in the second ESMO Deep Dive Webinar: an in-depth exploration of local treatment of non-colorectal cancers beyond surgery.
This instalment will focus on innovative techniques of local treatment of upper gastrointestinal and hepato-pancreatico-biliary malignancies beyond current state-of-the-art clinical practice. We believe this to be a particularly hot topic in the era of immunotherapy, with its implications in redefining the borders between oligometastatic and systemic disease.
The webinar will begin with a brief introduction, followed by three lectures on distinct aspects of the field delivered by international experts, Drs. Matthias Guckenberger, Max Seidensticker and Thierry de Baere. The webinar will conclude with a live discussion of questions submitted by the audience during the lectures.
We invite you and encourage you to register and join us in this new, highly specialised ESMO event.
Sincerely,
Magnus Nilsson
MD, PhD Professor of Surgery, Karolinska Institutet, Stockhom, Sweden
Senior Consultant Surgeon, Karolinska University Hospital, Stockhom, Sweden
AND
Jens Ricke
Chair of the Department of Radiology at University Hospital, LMU, Munich
Speakers
Programme
Time |
Title |
Speaker |
---|---|---|
5 min |
Welcome and Introduction |
Prof. Magnus Nilsson, Prof. Jens Ricke |
25 min |
Oligometastatic disease: a case for personalised craftsmanship |
Matthias Guckenberger |
25 min |
The toolbox of image guided tumour ablation – a technical rehearsal |
Max Seidensticker, Stefanie Corradini |
25 min |
HCC and CCC: ablation in the era of immunotherapy and molecular tumour boards |
Thierry de Baere |
15 min |
LIVE Q & A |
All |
A certificate of attendance and 1 ESMO MORA category point will be awarded for live attendance at this event.
Learning objectives:
- When to consider local treatments in a metastatic setting
- Biology considerations for selecting ablative and systemic therapeutic modalities
- Interventional Radiology and Radiotherapy perspectives on established local ablation approaches
- Understanding the role of image-guided ablation in primary liver cancer and exploring synergisms with systemic targeted therapies